Client Presentation Materials
Guidance on positioning GLP-1 cost containment with employer clients using structured, evidence-based materials.
Overview
Client presentation materials support conservative, evidence-based positioning of managed GLP-1 tapering programs. All materials undergo clinical and legal review and are adapted to specific client contexts during partner engagements.
Executive Presentations
Executive presentation materials are designed for initial C-suite introductions when the audience includes CFOs, CHROs, or benefits committee leadership.
When Used
During first meetings where the GLP-1 cost problem is being established and managed containment is introduced as a solution. Content is adapted based on client industry and decision-making structure.
Content Structure
- →Market context: Establishes the GLP-1 cost trajectory and employer exposure.
- →Client-specific analysis: Incorporates cost exposure data relevant to the specific client.
- →Case studies: Selected based on client industry and population characteristics.
- →Next steps: Aligned with client decision-making timeline and governance.
Key Positioning Principles
- • Lead with the problem — Establish cost exposure before introducing the solution.
- • Emphasize clinical safety — Position as clinical optimization, not purely financial.
- • Use conservative projections — Present ranges, never guarantees.
- • Propose pilot validation — End with controlled pilot rather than full deployment.
CFO Briefing Materials
Concise executive materials designed for financial decision-makers, typically used as leave-behinds after executive meetings or as pre-read material before CFO discussions.
Content Elements
- →Cost exposure summary: Client-specific figures expressed in basis points of pharmacy budget.
- →ROI projections: Conservative estimates with confidence intervals and PMPM impact.
- →Implementation timeline: Adjusted to reflect client fiscal year and decision cycles.
Financial Framing Guidelines
- • Express costs in basis points of pharmacy budget for comparability.
- • Include per-member-per-month (PMPM) impact alongside aggregate figures.
- • Present savings as ranges with confidence intervals, never guarantees.
- • Include implementation timeline to set expectations on savings realization.
HR and Benefits Leader Materials
Structured materials addressing employee experience and program concerns, designed for distribution to HR leadership and benefits managers before internal stakeholder meetings.
Key Questions Addressed
“How will employees be affected?”
Explains voluntary participation, member communication approach, and clinical safety protocols.
“Is this a coverage restriction?”
Clarifies that managed tapering is clinical optimization, not benefit reduction.
“What if employees complain?”
Outlines exception handling process and escalation paths.
“How do we communicate this internally?”
Provides internal communication guidance and timing recommendations.
Additional Engagement Materials
Benefits Committee Presentations
Materials for formal benefits committee presentations, including clinical evidence summary and governance considerations.
Broker Partner Materials
Materials for co-presenting with broker partners, developed in coordination with co-branding guidelines.
RFP Response Guidance
Pre-approved responses to common RFP questions about clinical programs and cost containment methodology.
Usage Guidelines
- ✓Customize for audience — Materials are adapted to specific stakeholder groups and client contexts.
- ✓Maintain conservative positioning — Claims and projections remain within clinically and legally reviewed bounds.
- ✗Do not guarantee outcomes — All projections are presented as ranges with appropriate caveats.
- ✗Do not modify clinical claims — Clinical statements are reviewed; modifications require coordination.
Questions about presentation materials or positioning approach?
Contact Partnerships